Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)

NCT00637195 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Papillomavirus
Papillomavirus Vaccines

Interventions

BIOLOGICAL: Subjects received 3 doses of GSK Biologicals' HPV vaccine (580299) (Cervarix™)
BIOLOGICAL: Engerix™

Sponsor

GlaxoSmithKline